Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mycology Research Laboratories (MRL) is a biotechnology company specializing in the development and production of mushroom-based nutritional supplements. The company utilizes a proprietary cultivation process to produce standardized mushroom biomass, including Maitake, Reishi, and Coriolus versicolor, which contain both mycelium and primordia. These products are designed to maintain the full spectrum of bioactive compounds, such as beta-glucans and essential enzymes, ensuring high bioavailability. MRL focuses on the clinical application of these products, particularly in supporting the immune system and addressing conditions such as HPV and chronic fatigue syndrome. Their products are manufactured to Good Manufacturing Practice (GMP) standards and are widely utilized by healthcare practitioners globally. The company is recognized for its commitment to clinical research, collaborating with various institutions to validate the efficacy of mycological nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maitake-MRL.